
|Articles|September 1, 2011
- Pharmaceutical Executive-09-01-2011
- Volume 0
- Issue 0
Pharmaceutical Executive Digital Edition - September 2011
From Many, One
Advertisement
Articles in this issue
about 15 years ago
Pharm Exec's 10th Annual Industry Auditabout 15 years ago
Pharma and Social Media: Ready to Make Nice?about 15 years ago
The Power of Product Development Partnershipabout 15 years ago
Front and Center in the Fight against TBabout 15 years ago
How to Recruit 70,000 People in One Yearabout 15 years ago
Innovating Around Innovationabout 15 years ago
India: Good Endings, Good Beginnings!about 15 years ago
Two Million Man Hoursabout 15 years ago
Rebates and Reformabout 15 years ago
Should the US Gamble with Risk Sharing?Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
HHS Confirms Four Senior FDA Leaders, Including Agency's First-Ever AI Deputy Commissioner
2
How Elevated Cortisol Levels Can Impact Type II Diabetes Treatments
3
Kura Oncology Spins Out Caspian Therapeutics With $50 Million to Test Menin Inhibition as a Disease-Modifying Approach to Diabetes
4
IBD's Most Persistent Gap: Q&A with Christian Thienel
5




